Erratum: ‘Corrigendum to “Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia” [Molecular Metabolism 5 (2) (2015) 67–78]’ (Molecular Metabolism (2016) 5(2) (67–78), (S2212877815002161), (10.1016/j.molmet.2015.11.004));Ataxin-10 is part of a cachexokine cocktail triggering cardiac metabolic dysfunction in cancer cachexia

Molecular Metabolism

Volumn 5, Issue 2, 2016, Pages 67-78

  Schäfer, Michaela ^a,b,c,j   Oeing, Christian U ^b,c   Rohm, Maria ^a,b,j   Baysal Temel, Ezgi ^b,c   Lehmann, Lorenz H ^b,c   Bauer, Ralf ^b,c   Volz, H Christian ^c,f   Boutros, Michael ^c,f   Sohn, Daniela ^a,b,j   Sticht, Carsten ^d   Gretz, Norbert ^d   Eichelbaum, Katrin ⁱ   Werner, Tessa ^c,h   Hirt, Marc N ^c,h   Eschenhagen, Thomas ^c,h   Müller Decker, Karin ^f   Strobel, Oliver ^g   Hackert, Thilo ^g   Krijgsveld, Jeroen ^e   Katus, Hugo A ^b,c   Berriel Diaz, Mauricio ^a,b,j   Backs, Johannes ^b,c   Herzig, Stephan ^a,b,c,j   more..

^a INSTITUTE OF EPIDEMIOLOGY   (Germany)

^b UNIVERSITY HOSPITAL HEIDELBERG   (Germany)

^c DZHK GERMAN CENTRE FOR CARDIOVASCULAR RESEARCH   (Germany)

^d UNIVERSITY OF MANNHEIM   (Germany)

^e EUROPEAN MOLECULAR BIOLOGY LABORATORY   (Germany)

^f GERMAN CANCER RESEARCH CENTER DKFZ   (Germany)

^g UNIVERSITY OF HEIDELBERG   (Germany)

^h UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

ⁱ MAX DELBRÜCK CENTER FOR MOLECULAR MEDICINE   (Germany)

^j GERMAN CENTER FOR DIABETES RESEARCH DZD   (Germany)

more..

Author keywords

Ataxin 10; Cancer cachexia; Cardiac dysfunction; Fatty acid metabolism

Indexed keywords

AGGRECANASE 1; ATAXIN 10; BRIDGING INTEGRATOR 1; CACHEXOKINE; CHEMOKINE; CHEMOKINE LIGAND 2; CYTOKINE; GLUCOSIDASE; GLUCOSIDASE ALPHA ACID; MULTIPLE INOSITOL POLYPHOSPHATE PHOSPHATASE 1; PHOSPHATASE; SYNTAXIN; SYNTAXIN 7; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; ATROPHY; CACHEXIA; CANCER CELL; COLON CANCER; CONTROLLED STUDY; FATTY ACID METABOLISM; FEMALE; HEART MUSCLE CELL; HEART MUSCLE METABOLISM; HUMAN; HUMAN CELL; MALE; METABOLIC DISORDER; MOUSE; NEWBORN; NONHUMAN; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; PROTEIN SECRETION; RAT;

EID: 84958058862     PISSN: None     EISSN: 22128778     Source Type: Journal    
DOI: 10.1016/j.molmet.2020.02.013     Document Type: Erratum

References (42)

1. Fearon K., Arends J., Baracos V. Understanding the mechanisms and treatment options in cancer cachexia. Nature Reviews Clinical Oncology 2013, 10:90-99.
2. Springer J., Tschirner A., Haghikia A., von Haehling S., Lal H., Grzesiak A., et al. Prevention of liver cancer cachexia-induced cardiac wasting and heart failure. European Heart Journal 2014, 35:932-941.
3. Dewys W.D., Begg C., Lavin P.T., Band P.R., Bennett J.M., Bertino J.R., et al. Prognostic effect of weight loss prior to chemotherapy in cancer patients. Eastern Cooperative Oncology Group. American Journal of Medicine 1980, 69:491-497.
4. Tisdale M.J. Cachexia in cancer patients. Nature Reviews Cancer 2002, 2:862-871.
5. Martignoni M.E., Kunze P., Hildebrandt W., Kunzli B., Berberat P., Giese T., et al. Role of mononuclear cells and inflammatory cytokines in pancreatic cancer-related cachexia. Clinical Cancer Research 2005, 11:5802-5808.
6. Fearon K.C., Glass D.J., Guttridge D.C. Cancer cachexia: mediators, signaling, and metabolic pathways. Cell Metabolism 2012, 16:153-166.
7. Norton J.A., Moley J.F., Green M.V., Carson R.E., Morrison S.D. Parabiotic transfer of cancer anorexia/cachexia in male rats. Cancer Research 1985, 45:5547-5552.
8. Beutler B., Cerami A. Cachectin and tumour necrosis factor as two sides of the same biological coin. Nature 1986, 320:584-588.
9. Strassmann G., Fong M., Kenney J.S., Jacob C.O. Evidence for the involvement of interleukin 6 in experimental cancer cachexia. The Journal of Clinical Investigation 1992, 89:1681-1684.
10. Hirai K., Hussey H.J., Barber M.D., Price S.A., Tisdale M.J. Biological evaluation of a lipid-mobilizing factor isolated from the urine of cancer patients. Cancer Research 1998, 58:2359-2365.
11. Mantovani G., Madeddu C. Cancer cachexia: medical management. Support Care Cancer 2009, 18:1-9.
12. Wiedenmann B., Malfertheiner P., Friess H., Ritch P., Arseneau J., Mantovani G., et al. A multicenter, phase II study of infliximab plus gemcitabine in pancreatic cancer cachexia. The Journal of Supportive Oncology 2008, 6:18-25.
13. Berriel Diaz M., Krones-Herzig A., Metzger D., Ziegler A., Vegiopoulos A., Klingenspor M., et al. Nuclear receptor cofactor receptor interacting protein 140 controls hepatic triglyceride metabolism during wasting in mice. Hepatology 2008, 48:782-791.
14. Jones A., Friedrich K., Rohm M., Schafer M., Algire C., Kulozik P., et al. TSC22D4 is a molecular output of hepatic wasting metabolism. EMBO Molecular Medicine 2013, 5:294-308.
15. Cosper P.F., Leinwand L.A. Cancer causes cardiac atrophy and autophagy in a sexually dimorphic manner. Cancer Research 2011, 71:1710-1720.
16. Tisdale M.J. Are tumoral factors responsible for host tissue wasting in cancer cachexia?. Future Oncology 2010, 6:503-513.
17. Burch G.E., Phillips J.H., Ansari A. The cachetic heart. A clinico-pathologic, electrocardiographic and roentgenographic entity. Diseases of the Chest 1968, 54:403-409.
18. Tian M., Nishijima Y., Asp M.L., Stout M.B., Reiser P.J., Belury M.A. Cardiac alterations in cancer-induced cachexia in mice. International Journal of Oncology 2010, 37:347-353.
19. Tian M., Asp M.L., Nishijima Y., Belury M.A. Evidence for cardiac atrophic remodeling in cancer-induced cachexia in mice. International Journal of Oncology 2011, 39:1321-1326.
20. Muhlfeld C., Das S.K., Heinzel F.R., Schmidt A., Post H., Schauer S., et al. Cancer induces cardiomyocyte remodeling and hypoinnervation in the left ventricle of the mouse heart. PloS One 2011, 6:e20424.
21. Schmitt M., Pawlita M. High-throughput detection and multiplex identification of cell contaminations. Nucleic Acids Research 2009, 37:e119.
22. Eichelbaum K., Winter M., Diaz M.B., Herzig S., Krijgsveld J. Selective enrichment of newly synthesized proteins for quantitative secretome analysis. Nature Biotechnology 2012, 30:984-990.
23. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 2001, 25:402-408.
24. Subramanian A., Tamayo P., Mootha V.K., Mukherjee S., Ebert B.L., Gillette M.A., et al. Gene set enrichment analysis: a knowledge-based approach for interpreting genome-wide expression profiles. Proceedings of the National Academy of Sciences of the United States of America 2005, 102:15545-15550.
25. Fearon K., Strasser F., Anker S.D., Bosaeus I., Bruera E., Fainsinger R.L., et al. Definition and classification of cancer cachexia: an international consensus. Lancet Oncology 2011, 12:489-495.
26. Tanaka Y., Eda H., Tanaka T., Udagawa T., Ishikawa T., Horii I., et al. Experimental cancer cachexia induced by transplantable colon 26 adenocarcinoma in mice. Cancer Research 1990, 50:2290-2295.
27. Rosenberg S.A., Spiess P., Lafreniere R. A new approach to the adoptive immunotherapy of cancer with tumor-infiltrating lymphocytes. Science 1986, 233:1318-1321.
28. Labianca R., Merelli B. Screening and diagnosis for colorectal cancer: present and future. Tumori 2010, 96:889-901.
29. Kuraguchi M., Wang X.P., Bronson R.T., Rothenberg R., Ohene-Baah N.Y., Lund J.J., et al. Adenomatous polyposis coli (APC) is required for normal development of skin and thymus. PLoS Genetics 2006, 2:e146.
30. Eschenhagen T., Fink C., Remmers U., Scholz H., Wattchow J., Weil J., et al. Three-dimensional reconstitution of embryonic cardiomyocytes in a collagen matrix: a new heart muscle model system. FASEB Journal: Official Publication of the Federation of American Societies for Experimental Biology 1997, 11:683-694.
31. Lopaschuk G.D., Ussher J.R., Folmes C.D., Jaswal J.S., Stanley W.C. Myocardial fatty acid metabolism in health and disease. Physiological Reviews 2010, 90:207-258.
32. Conrad C.H., Brooks W.W., Hayes J.A., Sen S., Robinson K.G., Bing O.H. Myocardial fibrosis and stiffness with hypertrophy and heart failure in the spontaneously hypertensive rat. Circulation 1995, 91:161-170.
33. Matsuyama T., Ishikawa T., Okayama T., Oka K., Adachi S., Mizushima K., et al. Tumor inoculation site affects the development of cancer cachexia and muscle wasting. International Journal of Cancer. Journal International du Cancer 2015, 137:2558-2565.
34. Lapiere C.M., Nusgens B., Pierard G.E. Interaction between collagen type I and type III in conditioning bundles organization. Connective Tissue Research 1977, 5:21-29.
35. Busquets S., Almendro V., Barreiro E., Figueras M., Argiles J.M., Lopez-Soriano F.J. Activation of UCPs gene expression in skeletal muscle can be independent on both circulating fatty acids and food intake. Involvement of ROS in a model of mouse cancer cachexia. FEBS Letters 2005, 579:717-722.
36. Tzika A.A., Fontes-Oliveira C.C., Shestov A.A., Constantinou C., Psychogios N., Righi V., et al. Skeletal muscle mitochondrial uncoupling in a murine cancer cachexia model. International Journal of Oncology 2013, 43:886-894.
37. Manne N.D., Lima M., Enos R.T., Wehner P., Carson J.A., Blough E. Altered cardiac muscle mTOR regulation during the progression of cancer cachexia in the ApcMin/+ mouse. International Journal of Oncology 2013, 42:2134-2140.
38. Argiles J.M., Busquets S., Toledo M., Lopez-Soriano F.J. The role of cytokines in cancer cachexia. Current Opinion in Supportive and Palliative Care 2009, 3:263-268.
39. Zhou X., Wang J.L., Lu J., Song Y., Kwak K.S., Jiao Q., et al. Reversal of cancer cachexia and muscle wasting by ActRIIB antagonism leads to prolonged survival. Cell 2010, 142:531-543.
40. Lokireddy S., Wijesoma I.W., Bonala S., Wei M., Sze S.K., McFarlane C., et al. Myostatin is a novel tumoral factor that induces cancer cachexia. The Biochemical Journal 2012, 446:23-36.
41. Cramer L., Hildebrandt B., Kung T., Wichmann K., Springer J., Doehner W., et al. Cardiovascular function and predictors of exercise capacity in patients with colorectal cancer. Journal of the American College of Cardiology 2014, 64:1310-1319.
42. Evangelista L.S., Moser D.K., Westlake C., Pike N., Ter-Galstanyan A., Dracup K. Correlates of fatigue in patients with heart failure. Progress in Cardiovascular Nursing 2008, 23:12-17.